Search alternatives:
mean decrease » a decrease (Expand Search)
nm decrease » a decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
nn decrease » a decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
_ decrease » _ decreased (Expand Search)
12 nm » 10 nm (Expand Search), 12 mm (Expand Search), 12 m (Expand Search)
_ nn » _ cnn (Expand Search), _ ann (Expand Search), _ knn (Expand Search)
Showing 1 - 20 results of 12,884 for search '(( 59 ((mean decrease) OR (_ decrease)) ) OR ((( 12 nm decrease ) OR ( _ nn decrease ))))*', query time: 0.53s Refine Results
  1. 1
    Mean-difference plots by country: Countries with decreased variance and decreased mean height (95% confidence interval shaded).

    Mean-difference plots by country: Countries with decreased variance and decreased mean height (95% confidence interval shaded). by Jewel Gausman (5210969)

    Published 2018
    Save to List
    Saved in:
  2. 2
    HRMECs treated with SUZ12 siRNA demonstrate increased miR-200b expression, decreased VEGF expression and decreased endothelial branching.

    HRMECs treated with SUZ12 siRNA demonstrate increased miR-200b expression, decreased VEGF expression and decreased endothelial branching. by Michael Anthony Ruiz (726055)

    Published 2015
    “…[NG+control siRNA = 5mM D-glucose + 100nM control siRNA, HG+control siRNA = 25mM D-glucose + 100nM control siRNA, HG+EZH2 siRNA = 25mM D-glucose + 100nM EZH2 siRNA, HG+SUZ12 siRNA = 25mM + 100nM SUZ12 siRNA; identical letters represent groups that are not significantly different; p < 0.05; n = 6; data expressed as mean ± SEM, normalized to U6 or β-actin and expressed as a fold change of NG+control siRNA].…”
    Save to List
    Saved in:
  3. 3
    Characterization of the optimized nanoparticles (These values are means of a minimum of 5 batches).

    Characterization of the optimized nanoparticles (These values are means of a minimum of 5 batches). by Anjuman Arora (750291)

    Published 2015
    Subjects:
    Save to List
    Saved in:
  4. 4
    Mean-difference plots by country: Countries with decreased variance and no change in mean height (95% confidence interval shaded).

    Mean-difference plots by country: Countries with decreased variance and no change in mean height (95% confidence interval shaded). by Jewel Gausman (5210969)

    Published 2018
    Save to List
    Saved in:
  5. 5
    Mean-difference plots by country: Countries with decreased variance and increased mean height (95% confidence interval shaded).

    Mean-difference plots by country: Countries with decreased variance and increased mean height (95% confidence interval shaded). by Jewel Gausman (5210969)

    Published 2018
    Save to List
    Saved in:
  6. 6
    Mean-difference plots by country: Countries with increased variance and decreased mean height (95% confidence interval shaded).

    Mean-difference plots by country: Countries with increased variance and decreased mean height (95% confidence interval shaded). by Jewel Gausman (5210969)

    Published 2018
    Save to List
    Saved in:
  7. 7
    Mean-difference plots by country: Countries with no change in variance and decreased mean height (95% confidence interval shaded).

    Mean-difference plots by country: Countries with no change in variance and decreased mean height (95% confidence interval shaded). by Jewel Gausman (5210969)

    Published 2018
    Save to List
    Saved in:
  8. 8
    Rapamycin treatment significantly decreases induction of lytic KSHV proteins.

    Rapamycin treatment significantly decreases induction of lytic KSHV proteins. by Lisa A. Nichols (357612)

    Published 2013
    Save to List
    Saved in:
  9. 9
    Mean change in incidence and diagnoses if testing rates decrease.

    Mean change in incidence and diagnoses if testing rates decrease. by Richard T. Gray (282417)

    Published 2013
    Save to List
    Saved in:
  10. 10
    Adjusted means and 95% confidence interval of blood pressure change from baseline to the follow-up in different general or abdominal obesity status change groups.

    Adjusted means and 95% confidence interval of blood pressure change from baseline to the follow-up in different general or abdominal obesity status change groups. by Yi-de Yang (6755798)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  11. 11
    The ratio of standard deviation to mean dose (SD/mean) decreases with neuronal dose.

    The ratio of standard deviation to mean dose (SD/mean) decreases with neuronal dose. by Murat Alp (781371)

    Published 2015
    Save to List
    Saved in:
  12. 12
    Rapamycin decreases Schwann cell markers, whereas statin induces Schwann cell markers.

    Rapamycin decreases Schwann cell markers, whereas statin induces Schwann cell markers. by Andrea Preitschopf (629851)

    Published 2014
    Save to List
    Saved in:
  13. 13
    Top k-NN clusters of metabolites decreased at 4 hours.

    Top k-NN clusters of metabolites decreased at 4 hours. by Zarazuela Zolkipli-Cunningham (5234186)

    Published 2021
    Save to List
    Saved in:
  14. 14
    Top k-NN cluster of metabolites decreased at 30 minutes.

    Top k-NN cluster of metabolites decreased at 30 minutes. by Zarazuela Zolkipli-Cunningham (5234186)

    Published 2021
    Save to List
    Saved in:
  15. 15
    Translocation of EHEC-Hly to mitochondria results in cytosolic cytochrome c release and ΔΨ<sub>m</sub> decrease.

    Translocation of EHEC-Hly to mitochondria results in cytosolic cytochrome c release and ΔΨ<sub>m</sub> decrease. by Martina Bielaszewska (79970)

    Published 2013
    Save to List
    Saved in:
  16. 16
    Single wavelength dose response kinetics for MS2. 254 = LP 254 nm and 285 = UV LED 285 nm.

    Single wavelength dose response kinetics for MS2. 254 = LP 254 nm and 285 = UV LED 285 nm. by Daniel Ma (12698752)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 17
    Mean daily consultation counts.

    Mean daily consultation counts. by Yael Rachamin (6161423)

    Published 2019
    Save to List
    Saved in:
  18. 18
    <i>In-vitro</i> drug release profiles of (a) amlodipine, (b) hydrochlorothiazide, and (c) candesartan.

    <i>In-vitro</i> drug release profiles of (a) amlodipine, (b) hydrochlorothiazide, and (c) candesartan. by Anjuman Arora (750291)

    Published 2015
    Subjects:
    Save to List
    Saved in:
  19. 19
    FT-IR spectra of (a) amlodipine (b) hydrochlorohiazide and (c) candesartan nanoparticles.

    FT-IR spectra of (a) amlodipine (b) hydrochlorohiazide and (c) candesartan nanoparticles. by Anjuman Arora (750291)

    Published 2015
    Subjects:
    Save to List
    Saved in:
  20. 20
    PK profiles of the developed nanoparticles vs. free drugs in rats (a) amlodipine, (b) hydrochlorothiazide, and (c) candesartan.

    PK profiles of the developed nanoparticles vs. free drugs in rats (a) amlodipine, (b) hydrochlorothiazide, and (c) candesartan. by Anjuman Arora (750291)

    Published 2015
    Subjects:
    Save to List
    Saved in:

Search Tools: